Following Vijay Kumar's exit, acting CBER Director Karim Mikhail will oversee a review office that has become a battleground for debates on FDA flexibility.[2255838] Rush health system CEO Dr. Omar Lateef is set to step down in 2027, with the company citing a longer transition period to ensure stability during the search for his replacement.[2151666]